Bronchospasm
3
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
2
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
ViiV HealthcareNC - Durham
3 programs1
2
Fluticasone propionate/salmeterolPhase 4
Fluticasone propionate/salmeterolPhase 4
GSK615915APhase 1
GSKLONDON, United Kingdom
2 programsFluticasone propionate/salmeterolPHASE_41 trial
Fluticasone propionate/salmeterolPHASE_41 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
GSKFluticasone propionate/salmeterol
GSKFluticasone propionate/salmeterol
Clinical Trials (2)
Total enrollment: 475 patients across 2 trials
A Study Measuring Asthma Control In Pediatric And Adolescent Subjects Whose Asthma Is Worsened By Activity Or Exercise
Start: Dec 2003Est. completion: Apr 2006248 patients
Phase 4Completed
A Study Measuring Asthma Control In Pediatric And Adolescent Subjects Whose Asthma Is Worsened By Activity Or Exercise
Start: Dec 2003Est. completion: Dec 2005227 patients
Phase 4Completed
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.